Related Experiment Video
Updated: Feb 4, 2026
03:26
Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
Published on: March 8, 2024
3.5K
A Personal Decision Support System for Heart Failure Management (HeartMan): study protocol of the HeartMan randomized
Anneleen Baert1, Els Clays1, Larissa Bolliger1
1Department of Public Health, Ghent University, University Hospital Ghent, entrance 42 (4K3) Corneel Heymanslaan 10, 9000, Ghent, Belgium.
BMC Cardiovascular Disorders
|September 29, 2018
Summary
This study investigated the HeartMan mobile health system for heart failure (HF) patients. The system aims to improve self-care and quality of life through personalized guidance on exercise, nutrition, medication, and mental support.
Area of Science:
- Cardiology
- Digital Health
- Health Services Research
Background:
- Heart failure (HF) is a widespread chronic condition lacking a cure, necessitating improved disease management strategies.
- Mobile health (mHealth) presents a promising technological avenue for enhancing HF patient care.
- The HeartMan study focuses on leveraging mHealth for better self-management in heart failure patients.
Purpose of the Study:
- To assess the impact of a personalized mHealth system, HeartMan, on disease management and health-related quality of life (HRQoL) in heart failure patients.
- To evaluate the efficacy of the HeartMan system as an adjunct to standard care for stable ambulatory HF patients.
Main Methods:
- A randomized controlled trial (1:2 ratio) involving 120 stable ambulatory HF patients with reduced ejection fraction across two European countries.
- The intervention group utilized the HeartMan platform, featuring a wristband sensor and decision support system for exercise, nutrition, medication adherence, and mental support.
- Primary endpoint: improvement in self-care and HRQoL after a six-month intervention. Secondary endpoints included behavioral, illness perception, clinical, and mental state outcomes.
Main Results:
- The study is designed to provide evidence on the effectiveness of the HeartMan system.
- Results will indicate whether advanced mHealth technology can enhance HRQoL in HF patients.
Conclusions:
- The HeartMan system represents a cutting-edge approach to HF self-management support.
- This trial will determine the potential of comprehensive mHealth solutions to improve the quality of life for individuals with heart failure.
Keywords:
Decision support systemDisease managementHealth-related quality of lifeHeart failuremHealthMore Related Videos
Related Concept Videos
01:30Heart Failure V: Medical Management
329
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
329
01:29Heart Failure II: Pathophysiology
948
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
948
01:17Pathophysiology of Heart Failure
3.7K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.7K
01:27Heart Failure I: Introduction
903
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
903
01:22Heart Failure VI: Adjunct Therapies
348
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
348
01:22Heart Failure Drugs: Diuretics
981
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
981